Effect of finasteride on serum concentrations of dihydrotestosterone and testosterone in three clinically normal sexually intact adult male dogs

American Journal of Veterinary Research

Volumn 59, Issue 6, 1998, Pages 762-764

  Kamolpatana, Kaitkanoke ^a   Johnston, Shirley D ^a   Hardy, Sharon K ^b   Castner, Susan ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; FINASTERIDE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DOG; DOSE RESPONSE; HYPOTHESIS; MALE; NONHUMAN; PROSTATE HYPERTROPHY; RADIOIMMUNOASSAY; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT INDICATION; TREATMENT PLANNING;

ANALYSIS OF VARIANCE; ANIMALS; DIHYDROTESTOSTERONE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FINASTERIDE; MALE; REFERENCE VALUES; SEXUAL MATURATION; TESTOSTERONE; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031868015     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Imperato-McGinley J, Guerreo L, Gautier T, et al. Steroid 5α-reductase deficiency in man: an inheirited form of male pseudohermaphroditism. Science 1974;18:1213-1215.
2. Russell DW, Wilson JD. Steroid 5α-reductase: two genes/ two enzymes. Annu Rev Biochem 1944;63:25-61.
3. Lee C, Kozlowski JM, Grayhack JT. Etiology of benign prostatic hypertroplasia. Urol Clin North Am 1995;22:237-246.
4. Grino PB, Griffin JE, Wilson JD. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 1990;126:1165-1172.
5. Anderson KM, Liao S. Selective retension of dihydrotestosterone by prostatic nuclei. Nature 1968;219:277-279.
6. Cohen SM, Werrmann JG, Rasmusson GH, et al. Comparison of the effects of new specific azasteroid inhibitors of steroid 5α-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression. Prostate 1995;26:55-71.
7. American Society of Andrology. Handbook of andrology. Lawrence, Kan: Allen Press, 1995;76-79.
8. Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992;327:1185-1191.
9. Stoner E. 5α-reductase inhibitors/finasteride. Prostate Suppl 1996;6:82-87.
10. Moore E, Bracken B, Bremner W, et al. Proscar: five-year experience. Eur-Urol 1995;28:304-309.
11. Anderson JT, Ekman P, Wolf H, et al. Can finastende reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. Urology 1995;46:631-637.
12. Laroque PA, Prahalada S, Molon-Noblot S, et al. Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors. Prostate 1995;27:121-128.
13. Steel RGD, Torrie JH. Principles and procedures of statistics: a biological approach. 2nd ed. New York: McGraw-Hill Inc. 1980; 297-301.
14. Winter ML, Bosland MC, Wade DR. Induction of benign prostatic hyperplasia in intact dogs with near-physiological levels of 5α-dihydrotestosterone and 17β-estradiol. Prostate 1995;26:325-333.
15. Olson PN. Clinical approach to infertility in the stud dog, in Proceedings. Annu Soc Theriogenol 1984;33-45.
16. Larsen RE, Johnston SD. Management of canine infertility. In: Kirk RW, ed. Current veterinary therapy VII. Philadelphia: WB Saunders Co, 1980;1226-1231.
17. Cochran RC, Ewing LL, Niswender GD. Serum levels of FSH LH PRL, T, DHT, 5α-androstane-3α, 17 β-diol, 5α-androstane-3β, and 17-β-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia. Invest Urol 1981;19:142-147.
18. The Finasteride Study Group. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. Prostate 1993;22:291-299.
19. Levy MA, Brandt M, Sheedy KM. Cloning, expression and functional characterization of type 1 and type 2 steroid 5α-reductases from Cynomolgus monkey: comparisons with human and rat isozymes. J Steroid Biochem Molec Biol 1995;52:307-319.
20. Harris G, Azzolina B, Baginsky W. Identification and selective inhibition of an isozyme of steroid 5α-reductase in human scalp. Proc Natl Acad Sci 1992;89:10787-10791.
21. Rhodes L. The role of dihydrotestosterone in prostate physiology: comparison among rats, dogs and primates, in Proceedings. Annu Soc Theriogenol 1996;124-135.